How do oxidized phospholipids inhibit LPS signaling?
Mackman
Nigel
N
D018932:Chemokine CCL2 / Q000378:metabolism*; D016209:Interleukin-8 / Q000378:metabolism*; D018950:Lipopolysaccharide Receptors / Q000502:physiology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism*; D010084:Oxidation-Reduction; D010713:Phosphatidylcholines / Q000502:physiology*; D010743:Phospholipids / Q000502:physiology
C468114:1-palmitoyl-2-arachidonyl-3-phosphorylcholine; D018932:Chemokine CCL2; D016209:Interleukin-8; D018950:Lipopolysaccharide Receptors; D008070:Lipopolysaccharides; D010713:Phosphatidylcholines; D010743:Phospholipids